Fund Holdings — Samsara BioCapital, LLC

Total Portfolio Value:
$520.28M
Total Bought:
$41.20M
Total Sold:
$18.48M
Net Transaction:
+$22.73M
Notable People:
Michael Philip Dybbs
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Cargo Therapeutics Inc4,415,6894,415,6890$72.51M$81.47M15.66%+$8.96M
Mineralys Therapeutics, Inc.(MLYS)5,074,9165,074,9160$59.38M$61.46M11.81%+$2.08M
Scholar Rock Holding Corporation(SRRK)6,788,6096,788,6090$56.55M$54.38M10.45%-$2.17M
Neurogene Inc.(NGNE)1,267,7901,267,7900$46.13M$53.20M10.22%+$7.06M
Alumis Inc03,266,498+3,266,498$0$34.89M6.71%+$34.89M
Arcellx Inc
COMMON STOCK
453,641353,641-100,000$25.04M$29.53M5.68%+$4.50M
LENZ Therapeutics, Inc.(LENZ)1,208,4731,208,4730$20.89M$28.69M5.51%+$7.79M
Nkarta, Inc.(NKTX)3,768,0353,768,0350$22.27M$17.03M3.27%-$5.24M
Climb Bio, Inc.(CLYM)3,261,3932,609,114-652,279$23.19M$13.28M2.55%-$9.91M
Avadel Pharmaceuticals Plc967,527967,5270$13.60M$12.69M2.44%-$914.3K
Zymeworks Inc.(ZYME)1,000,0001,000,0000$8.51M$12.55M2.41%+$4.04M
Acelyrin Inc2,523,0222,523,0220$11.13M$12.44M2.39%+$1.31M
Contineum Therapeutics, Inc.CL A(CTNM)588,817588,816-1$10.37M$11.27M2.17%+$900.9K
Jasper Therapeutics, Inc.(JSPR)525,000584,642+59,642$11.92M$11.00M2.11%-$920.4K
ABIVAX Société AnonymeADS(ABVX)850,000850,0000$11.24M$9.79M1.88%-$1.45M
Rhythm Pharmaceuticals, Inc.(RYTM)172,647172,6470$7.09M$9.04M1.74%+$1.96M
Inozyme Pharma Inc1,562,5001,562,5000$6.97M$8.17M1.57%+$1.20M
Sutro Biopharma, Inc.(STRO)2,196,8142,196,8140$6.44M$7.60M1.46%+$1.16M
Cypherpunk Technologies Inc.(CYPH)2,442,3522,442,3520$4.79M$6.28M1.21%+$1.49M
Gossamer Bio, Inc.(GOSS)6,130,2686,130,2680$5.52M$6.05M1.16%+$524.1K
Verona Pharma PlcADS347,500195,225-152,275$5.02M$5.62M1.08%+$591.8K
Tango Therapeutics, Inc.(TNGX)630,000630,0000$5.41M$4.85M0.93%-$554.4K
Artiva Biotherapeutics, Inc.(ARTV)0291,666+291,666$0$4.51M0.87%+$4.51M
Syros Pharmaceuticals Inc1,786,4271,786,4270$9.22M$3.84M0.74%-$5.38M
Io Biotech Inc3,640,0153,640,0150$4.26M$3.82M0.73%-$436.8K
vTv Therapeutics Inc.CL A(VTVT)206,784206,7840$3.65M$2.81M0.54%-$846.8K
Immatics N.V.SHS(IMTX)198,000198,0000$2.30M$2.26M0.43%-$41.6K
Prime Medicine, Inc.(PRME)540,304540,3040$2.78M$2.09M0.40%-$686.2K
Day One Biopharmaceuticals I
COM
196,425147,319-49,106$2.71M$2.05M0.39%-$654.6K
Terns Pharmaceuticals Inc202,348202,3480$1.38M$1.69M0.32%+$309.6K
Hillevax Inc799,274799,2740$11.56M$1.41M0.27%-$10.15M
Janux Therapeutics, Inc.(JANX)45,05222,526-22,526$1.89M$1.02M0.20%-$863.9K
Bicara Therapeutics Inc035,000+35,000$0$891.5K0.17%+$891.5K
Aclaris Therapeutics, Inc.(ACRS)696,171696,1710$765.8K$800.6K0.15%+$34.8K
Lyra Therapeutics Inc2,780,2612,780,2610$769.3K$714.5K0.14%-$54.8K
Bolt Biotherapeutics Inc1,049,1531,049,1530$786.9K$679.9K0.13%-$107.0K
Viracta Therapeutics Inc689,709689,7090$375.0K$159.6K0.03%-$215.4K
Allakos Inc172,089172,0890$172.1K$112.4K0.02%-$59.7K
Kronos Bio Inc78,13178,1310$96.9K$78.1K0.02%-$18.8K
Allovir Inc82,33682,3360$59.6K$66.6K0.01%+$7.0K
Nuvation Bio Inc.W EXP 07 07 202(NUVB)133,333133,3330$21.3K$13.1K0.00%-$8.3K
Surrozen, Inc.W EXP 08 01 203(SRZN)99,99999,9990$1.7K$1.0K0.00%-$630
Igm Biosciences Inc154,6640-154,664$1.06M$0—-$1.06M
Page 1 of 1
Samsara BioCapital, LLC — 13F Holdings — Q3 2024 | TickerTrail